Miles Capital’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-3,998	Closed	-$297K	–	181
2016 Q2	$297K	Buy	3,998 +233	+6%	+$17.3K	0.2%	112
2016 Q1	$252K	Buy	+3,765	New	+$252K	0.17%	145